UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life

Annals of oncology, 2014-11, Vol.25 (11), p.2237-2243

2014

Volltextzugriff (PDF)

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non‐small‐cell lung cancer

Clinical and experimental immunology, 2015-06, Vol.180 (3), p.467-474

2015

Volltextzugriff (PDF)

Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma

Carcinogenesis (New York), 2020-07, Vol.41 (7), p.984-992

2020

Volltextzugriff (PDF)

Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1

European journal of cancer (1990), 2018-02, Vol.90, p.122-129

2018

Volltextzugriff (PDF)

Proffered Paper: Immunological changes during tumor progression from primary to recurrent glioblastoma

European journal of cancer (1990), 2016-07, Vol.61, p.S2-S2

2016

Volltextzugriff (PDF)

Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study

Pulmonology, 2024-04

2024

Volltextzugriff (PDF)

The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies

Oncogene, 2008-02, Vol.27 (9), p.1281-1289

2008

Volltextzugriff (PDF)

Non-clinical safety and antitumor efficacy of live attenuated Salmonella typhimurium-based oral T-cell vaccines VXM01m, VXM04m and VXM06m

European journal of cancer (1990), 2016-12, Vol.69, p.S106-S106

2016

Volltextzugriff (PDF)

892: Peripheral T cell responses in glioblastoma patients are associated with an improved survival

European journal of cancer (1990), 2014-07, Vol.50, p.S218-S218

2014

Volltextzugriff (PDF)

9 Proffered Paper: Identification and Evaluation of Tumor Associated Antigens in Head and Neck Patients

European journal of cancer (1990), 2012-07, Vol.48, p.S3-S3

2012

Volltextzugriff (PDF)

O6.06 PERIPHERAL T CELL RESPONSES IN GLIOBLASTOMA PATIENTS ARE ASSOCIATED WITH AN IMPROVED SURVIVAL

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii13-ii13

2014

Volltextzugriff (PDF)

UP-02.085 Antigen-Specific T-Cell Responses Against Tumor-Antigens Are Controlled by Regulatory T-Cells in Prostate Cancer Patients

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S289-S289

2011

Volltextzugriff (PDF)

355 Clonogenicity and in Vivo Growth Identify Two Types of Stem-like Glioblastoma Cells (SLGC) Differing in Tumorigenicity and Invasiveness

European journal of cancer (1990), 2012-07, Vol.48, p.S86-S86

2012

Volltextzugriff (PDF)

1101 Human Tumor Cells Inhibit T Cell Responses Through Expression of Carcinoembryonic-antigen-related Cell Adhesion Molecule-6 (CEACAM-6)

European journal of cancer (1990), 2012-07, Vol.48, p.S265-S265

2012

Volltextzugriff (PDF)

Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007

Cancer Immunology, Immunotherapy, 2008-09, Vol.57 (9), p.1421-1427

2008

Volltextzugriff (PDF)

Classification of current anticancer immunotherapies

Oncotarget, 2014-12, Vol.5 (24), p.12472-12508

2014

Volltextzugriff (PDF)

Potential target antigens for immunotherapy in human pancreatic cancer

Cancer letters, 2007-07, Vol.252 (2), p.290-298

2007

Volltextzugriff (PDF)

Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

International journal of oncology, 2006-06, Vol.28 (6), p.1419-1428

2006

Volltextzugriff (PDF)

SPONTANEOUS IMMUNE RESPONSES IN GBM PATIENTS AFTER COMPLETE TUMOR RESECTION ARE ASSOCIATED WITH AN IMPROVED SURVIVAL

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii42-iii42

2014

Volltextzugriff (PDF)

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells

International journal of oncology, 2002-02, Vol.20 (2), p.247

2002

Volltextzugriff (PDF)

Tumor-spezifische B-Zell Immunantworten bei Patientinnen mit operablem, primärem Mammakarzinom und deren Einfluss auf das Gesamtüberleben

Geburtshilfe und Frauenheilkunde, 2014, Vol.74 (S 01)

2014

Volltextzugriff (PDF)

Interaktionen zwischen Tumorantigen-reaktiven T-Zellen des Knochenmarks und Tumorzellen bei Patientinnen mit Mammakarzinom

Geburtshilfe und Frauenheilkunde, 2006-11, Vol.66 (11), p.1059-1065

2006

Volltextzugriff (PDF)

A screening for novel immune-checkpoints identifies a serine/threonine kinase to confer immune resistance in multiple myeloma

European journal of cancer (1990), 2019-03, Vol.110, p.S3-S4

2019

Volltextzugriff (PDF)

432 ADAM17 is a psoriasis-relevant check-point controlling Th17-programming by inflammatory dermal dendritic cells

Journal of investigative dermatology, 2016-09, Vol.136 (9), p.S234-S234

2016

Volltextzugriff (PDF)

Bone marrow as a priming site for T-cell responses to blood-borne antigen

Nature medicine, 2003-09, Vol.9 (9), p.1151-1157

2003

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(77)
Tagungsberichte
(15)

Sprache

Englisch
(75)
Deutsch
(19)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Humans
(28)
Oncology
(24)
Animals
(22)
Female
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(17)
Mice
(17)
Tumors
(17)
Immunotherapy
(13)
T-Lymphocytes - Immunology
(11)
Hematology, Oncology And Palliative Medicine
(10)
Middle Aged
(10)
Aged
(9)
Immunologic Memory
(9)
Immunology
(8)
Male
(8)
Pharmacology. Drug Treatments
(8)
Mice, Inbred Nod
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non‐small‐cell lung cancer

Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma

Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1

Proffered Paper: Immunological changes during tumor progression from primary to recurrent glioblastoma

Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study

The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies

Non-clinical safety and antitumor efficacy of live attenuated Salmonella typhimurium-based oral T-cell vaccines VXM01m, VXM04m and VXM06m

892: Peripheral T cell responses in glioblastoma patients are associated with an improved survival

9 Proffered Paper: Identification and Evaluation of Tumor Associated Antigens in Head and Neck Patients

O6.06 PERIPHERAL T CELL RESPONSES IN GLIOBLASTOMA PATIENTS ARE ASSOCIATED WITH AN IMPROVED SURVIVAL

UP-02.085 Antigen-Specific T-Cell Responses Against Tumor-Antigens Are Controlled by Regulatory T-Cells in Prostate Cancer Patients

355 Clonogenicity and in Vivo Growth Identify Two Types of Stem-like Glioblastoma Cells (SLGC) Differing in Tumorigenicity and Invasiveness

1101 Human Tumor Cells Inhibit T Cell Responses Through Expression of Carcinoembryonic-antigen-related Cell Adhesion Molecule-6 (CEACAM-6)

Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007

Classification of current anticancer immunotherapies

Potential target antigens for immunotherapy in human pancreatic cancer

Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

SPONTANEOUS IMMUNE RESPONSES IN GBM PATIENTS AFTER COMPLETE TUMOR RESECTION ARE ASSOCIATED WITH AN IMPROVED SURVIVAL

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells

Tumor-spezifische B-Zell Immunantworten bei Patientinnen mit operablem, primärem Mammakarzinom und deren Einfluss auf das Gesamtüberleben

Interaktionen zwischen Tumorantigen-reaktiven T-Zellen des Knochenmarks und Tumorzellen bei Patientinnen mit Mammakarzinom

A screening for novel immune-checkpoints identifies a serine/threonine kinase to confer immune resistance in multiple myeloma

432 ADAM17 is a psoriasis-relevant check-point controlling Th17-programming by inflammatory dermal dendritic cells

Bone marrow as a priming site for T-cell responses to blood-borne antigen

Suchergebnisse filtern